News Valneva

Equities

VLA

FR0004056851

Market Closed - Euronext Paris Other stock markets 11:37:14 2024-04-18 am EDT			5-day change	1st Jan Change
3.7 ^EUR	+2.78%		-6.19%	-21.61%

Apr. 11	Valneva: Deep Track Biotechnology Master holds less than 5% of the capital	CF
Mar. 26	Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Valneva : Document AMF CP. 2024E960493	Apr. 16	PU
Valneva: Deep Track Biotechnology Master holds less than 5% of the capital	Apr. 11	CF
World Vaccine Congress Washington: Antibody persistence of a single-dose live-attenuated chikungunya virus vaccine in adults	Apr. 04	PU
Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate	Mar. 26	MT
Valneva: Phase 1 trial initiated in the Zika virus	Mar. 26	CF
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate	Mar. 26	AQ
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate	Mar. 26	GL
Valneva SE Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate	Mar. 26	CI
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F	Mar. 25	GL
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F	Mar. 25	AQ
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook	Mar. 21	AQ
Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C.	Mar. 21	GL
ADRs End Higher; XTL Biopharmaceuticals Climbs 129%	Mar. 20	DJ
Valneva SE Raises Revenue Guidance for 2024	Mar. 20	CI
Valneva SE Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Transcript : Valneva SE, 2023 Earnings Call, Mar 20, 2024	Mar. 20
Valneva: share price down, forecasts below expectations	Mar. 20	CF
French biotech company Valneva raises product sales guidance	Mar. 20	RE
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook	Mar. 20	GL
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook	Mar. 20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer